Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy

NCT01904786 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT01904786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01904786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
Lead sponsor
St. Louis University
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2014
Completion date
November 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newborn hypoxic ischemic encephalopathy